Professor Ross Baker and the Perth Blood Institute’s Clinical Trials Unit have been part of the team to find a treatment to improve progression free survival in patients with relapsed indolent non-Hodgkin lymphoma. This publication is an interim analysis of the findings from a double-blind, randomised, placebo-controlled trial involving 186 academic medical centres throughout the world. Read more
Perth Blood Institute’s (PBI) Clinical Trials team played an instrumental role in the publication of findings for an important multicentre, open-label, randomised phase 3 trial for relapsed multiple myeloma. The results of the study were published in the highly prestigious peer-reviewed journal, The Lancet. Read more
Murdoch University PhD student Jiayin (Munik) Tian has been selected to publish her research in ‘Thrombosis and Haemostasis’, the International Journal for Vascular Biology and Medicine. Read more
Pancreatic cancer is one of the deadliest diseases. A recent study led by PBI Scientist Dr Omar Elaskalani has been published in a special issue of Cancers by MDPI, a peer-reviewed academic journal. The study offers promising evidence that a commonly used blood thinner may help pancreatic cancer patients. Read more